Skip to main content

XBiotech Inc.

XBIT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001626878

No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding XBiotech Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of XBIT: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders5666+10
Shares4.11M4.71M+596.8K (+14.5%)
Value$66.8M$56.7M−$10.0M (−15.0%)

New holders (12)

Institutions that held XBiotech Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to XBIT in Q3 2021
InstitutionSharesValue% of portfolio
Citadel Advisors LLC47,828$619.0K0.00%
HRT Financial LP35,844$464.0K0.00%
Oracle Investment Management Inc350,000$275.0K0.03%
Millennium Management LLC15,010$194.0K0.00%
SG Americas Securities, LLC12,735$165.0K0.00%
Virtu Financial LLC12,111$157.0K0.01%
Susquehanna International Group, LLP10,069$130.0K0.00%
MetLife Investment Management5,892$76.3K0.00%
The PNC Financial Services Group, Inc.5,000$65.0K0.00%
Metropolitan Life Insurance Co4,457$57.7K0.00%
Nisa Investment Advisors, LLC4,000$52.0K0.00%
Group One Trading, L.P.2,024$26.0K0.00%

Sold out (2)

Institutions that held XBiotech Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of XBIT in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Parametric Portfolio Associates LLC20,995$348.0K
Advisory Services Network, LLC200$3.00K